Candidate drug produces benefits

Encouraging results in progeria trial In a paper published Sept. 24 in the Proceedings of the National Academy of Sciences a team of physicians led by Dr. Leslie Gordon, associate professor of pediatrics (research), reported significant benefits from a candidate drug for children with progeria, a rare and fatal disease in which children appear to age very rapidly. The prognosis for the disease is never good, with children dying of athlerosclerosis typically by age 13.